NCT00925457View on ClinicalTrials.gov

Evaluating the Risk of Serious Ventricular Arrhythmia and Sudden Cardiac Death Among Users of Domperidone

CompletedOBSERVATIONAL
Enrollment

1,608

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Arrhythmias, Cardiac
Interventions
OTHER

No Intervention

Neither current domperidone nor current PPI

DRUG

Current Domperidone

Current domperidone at any dose, regardless of proton pump inhibitor status

DRUG

Current proton pump inhibitor (PPI)

Current PPI and not current dapoxetine

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00925457 - Evaluating the Risk of Serious Ventricular Arrhythmia and Sudden Cardiac Death Among Users of Domperidone | Biotech Hunter | Biotech Hunter